[Treatment of cerebral degenerative symptoms due to age. Double blind trial on the effect of Juston (author's transl)].
D000203:Activities of Daily Living; D000368:Aged; D000375:Aging; D001205:Ascorbic Acid / Q000627:therapeutic use; D002100:Cachexia / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010292:Paresthesia / Q000188:drug therapy; D010919:Placebos; D011736:Pyridoxine / Q000627:therapeutic use; D012256:Riboflavin / Q000627:therapeutic use; D013805:Theobromine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use; D014801:Vitamin A / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; D010919:Placebos; D014815:Vitamins; D014801:Vitamin A; D014810:Vitamin E; D011736:Pyridoxine; D013805:Theobromine; D001205:Ascorbic Acid; D012256:Riboflavin; D013831:Thiamine
Behandlung altersbedingter zerebraler Abbauerscheinunger. Doppelblindversuch mit Justin